Here's the live share price of Neuland Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Neuland Laboratories | 2.01 | 22.75 | 6.82 | -7.13 | 17.95 | 94.15 | 44.22 |
| Sun Pharmaceutical Industries | -1.30 | -4.91 | 1.55 | 2.13 | 0.14 | 19.31 | 21.78 |
| Divi's Laboratories | 3.68 | 1.67 | -0.92 | -6.39 | 7.28 | 25.00 | 10.30 |
| Torrent Pharmaceuticals | 1.23 | -2.80 | 3.11 | 17.27 | 28.64 | 37.71 | 26.42 |
| Lupin | 2.02 | 2.29 | 7.64 | 20.10 | 21.01 | 52.70 | 17.41 |
| Dr. Reddy's Laboratories | 0.49 | -4.45 | 3.64 | -1.75 | 5.07 | 7.88 | 4.70 |
| Cipla | 0.20 | -5.56 | -12.25 | -21.80 | -18.03 | 10.59 | 6.06 |
| Zydus Lifesciences | 3.75 | 5.61 | 7.86 | -4.88 | 13.85 | 23.10 | 13.18 |
| Mankind Pharma | 3.21 | 1.34 | -2.58 | -13.64 | -15.95 | 14.18 | 8.28 |
| Aurobindo Pharma | 2.69 | 7.52 | 17.33 | 24.40 | 21.42 | 35.05 | 8.50 |
| Alkem Laboratories | 3.83 | 4.76 | -4.46 | 0.94 | 12.48 | 18.75 | 15.20 |
| Glenmark Pharmaceuticals | 4.20 | 3.89 | 12.97 | 21.17 | 66.56 | 66.45 | 33.31 |
| Laurus Labs | 3.09 | 16.25 | 3.77 | 27.94 | 78.20 | 54.17 | 20.68 |
| Biocon | 1.16 | -7.17 | -7.36 | -2.33 | 6.29 | 16.04 | -2.87 |
| Abbott India | 0.66 | -2.66 | -6.51 | -12.96 | -15.45 | 4.84 | 11.69 |
| Anthem Biosciences | 1.21 | 13.41 | 18.46 | -5.57 | -0.16 | -0.05 | -0.03 |
| GlaxoSmithKline Pharmaceuticals | 1.76 | -0.14 | 2.26 | -11.97 | -17.99 | 24.31 | 10.41 |
| Ipca Laboratories | 1.70 | -5.19 | -2.29 | 14.49 | 4.72 | 21.86 | 7.01 |
| Ajanta Pharma | 4.73 | -2.44 | 7.45 | 16.40 | 9.30 | 31.42 | 20.46 |
| J B Chemicals & Pharmaceuticals | 0.52 | -5.16 | 4.17 | 18.54 | 21.73 | 22.76 | 26.38 |
Over the last one year, Neuland Laboratories has gained 17.95% compared to peers like Sun Pharmaceutical Industries (0.14%), Divi's Laboratories (7.28%), Torrent Pharmaceuticals (28.64%). From a 5 year perspective, Neuland Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (21.78%) and Divi's Laboratories (10.30%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 14,287.49 | 14,506.43 |
| 10 | 13,378.7 | 13,925.83 |
| 20 | 12,758.93 | 13,387.76 |
| 50 | 12,997.61 | 13,335.91 |
| 100 | 14,251.91 | 13,777.1 |
| 200 | 14,372.59 | 13,870.14 |
In the latest quarter, Neuland Laboratories remained same as its previous close in promoter holding, while DII stake increased to 15.84%, FII holding fell to 20.46%, and public shareholding moved down to 31.08% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 2,69,243 | 1.75 | 323.82 | |
| 1,61,718 | 1.4 | 194.5 | |
| 82,359 | 1.65 | 99.05 | |
| 73,810 | 1.57 | 88.77 | |
| 68,758 | 2.16 | 82.7 | |
| 57,513 | 0.34 | 69.17 | |
| 45,345 | 0.08 | 54.54 | |
| 44,855 | 1.81 | 53.95 | |
| 36,983 | 0.93 | 44.48 | |
| 34,378 | 2.84 | 41.35 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Apr 09, 2026, 09:59 PM IST IST | Neuland Laboratories - Compliance Certificate Pursuant To SEBI Exemption Order Dated January 3, 2025 For The Financial Year E |
| Apr 02, 2026, 08:45 PM IST IST | Neuland Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Apr 01, 2026, 07:13 PM IST IST | Neuland Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Mar 03, 2026, 10:31 PM IST IST | Neuland Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Mar 03, 2026, 05:13 PM IST IST | Neuland Laboratories - Announcement under Regulation 30 (LODR)-Demise |
Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 1476.84 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Neuland Laboratories is ₹15,029.10 as on Apr 15, 2026.
The Neuland Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Neuland Laboratories is ₹19,282.17 Cr as on Apr 15, 2026.
Today’s highest and lowest price of Neuland Laboratories are ₹15,099.95 and ₹14,469.90.
The 52-week high/low is the highest and lowest price at which Neuland Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Neuland Laboratories is ₹19,748.40 and 52-week low of Neuland Laboratories is ₹10,598.05 as on Apr 15, 2026.
The Neuland Laboratories has shown returns of 3.37% over the past day, 22.75% for the past month, 5.33% over 3 months, 18.76% over 1 year, 94.15% across 3 years, and 44.22% over 5 years.
P/E ratio of and PB ratio of Neuland Laboratories are 107.64 and 11.61 on Apr 15, 2026. While the company gives a dividend yield of 0.08 per annum.